Search Results - "Souilhac, J."

Refine Results
  1. 1
  2. 2

    Blockade of cannabinoid receptors by SR141716 selectively increases fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function by ALONSO, R, VOUTSINOS, B, FOURNIER, M, LABIE, C, STEINBERG, R, SOUILHAC, J, LE FUR, G, SOUBRIE, P

    Published in Neuroscience (01-06-1999)
    “…The present study investigated, in rats, whether blockade of cannabinoid CB1 receptors may alter Fos protein expression in a manner comparable to that observed…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Expression and presence of septal neurokinin-2 receptors controlling hippocampal acetylcholine release during sensory stimulation in rat by Steinberg, R., Marco, N., Voutsinos, B., Bensaid, M., Rodier, D., Souilhac, J., Alonso, R., Oury-Donat, F., Fur, G.Le, Soubrie, P.

    Published in The European journal of neuroscience (01-07-1998)
    “…We examined the expression and presence of NK2 receptors in the septal area of rat brain, and investigated their functional role in the regulation of the…”
    Get full text
    Journal Article
  5. 5

    Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice by Souilhac, J., Poncelet, M., Rinaldi-Carmona, M., Le Fur, G., Soubrié, P.

    Published in Pharmacology, biochemistry and behavior (01-05-1995)
    “…When injected unilaterally into the mouse striatum, cannabinoid agonists such as Win 55212-2 (1–100 ng/mouse), CP 55940 (0.1–50 ng/mouse), and anandamide…”
    Get full text
    Journal Article
  6. 6

    Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation by Steinberg, R, Souilhac, J, Rodier, D, Alonso, R, Emonds-Alt, X, Le Fur, G, Soubrié, P

    Published in Neuroscience (01-05-1998)
    “…The regulation of striatal cholinergic function by dopamine D1 receptor activation was examined in vivo in urethane-anaesthetized rats with microdialysis…”
    Get full text
    Journal Article
  7. 7

    SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission by Steinberg, R, Brun, P, Fournier, M, Souilhac, J, Rodier, D, Mons, G, Terranova, J P, Le Fur, G, Soubrié, P

    Published in Neuroscience (01-04-1994)
    “…Unilateral microinjection of neurotensin in the ventral tegmental area of the rat (2.5 micrograms/0.5 microliter) produced behavioural excitation illustrated…”
    Get more information
    Journal Article
  8. 8

    Pharmacological characterization of tachykinin receptors controlling acetylcholine release from rat striatum: an in vivo microdialysis study by Steinberg, R, Rodier, D, Souiclhac, J, Bougault, I, Emonds-Alt, X, Soubrié, P, Le Fur, G

    Published in Journal of neurochemistry (01-12-1995)
    “…The regulation of striatal cholinergic function by tachykinins was examined in urethane-anesthetized rats by using microdialysis. Substance P (0.01-1 microM),…”
    Get more information
    Journal Article
  9. 9

    Electrophysiological, behavioural and biochemical evidence for activation of brain noradrenergic systems following neurokinin NK3 receptor stimulation by JUNG, M, MICHAUD, J. C, STEINBERG, R, BARNOUIN, M. C, HAYAR, A, MONS, G, SOUILHAC, J, EMONDS-ALT, X, SOUBRIE, P, LE FUR, G

    Published in Neuroscience (01-09-1996)
    “…The objective of the present in vitro and in vivo experiments was to examine the involvement of neurokinin NK3 receptors in the regulation of the noradrenergic…”
    Get full text
    Journal Article
  10. 10

    Neuropharmacological characterization of SR 140333, a non peptide antagonist of NK1 receptors by Jung, M, Calassi, R, Maruani, J, Barnouin, M C, Souilhac, J, Poncelet, M, Gueudet, C, Emonds-Alt, X, Soubrié, P, Brelière, J C

    Published in Neuropharmacology (01-02-1994)
    “…SR 140333 (1-[2-[3-(3,4-dichlorophenyl)-1-(3-isopropoxyphenylacetyl) piperidin-3-yl]ethyl]-4-phenyl-1-azonia-bicyclo[2.2.2]octane , chloride), a potent non…”
    Get more information
    Journal Article
  11. 11

    Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats by PONCELET, M, SOUILHAC, J, GUEUDET, C, TERRANOVA, J. P, GULLY, D, LE FUR, G, SOUBRIE, P

    Published in Psychopharmacologia (01-10-1994)
    “…One major mechanism underlying the central action of neurotensin is an interaction with the function of dopamine (DA)-containing neurons. In addition, direct…”
    Get full text
    Journal Article
  12. 12

    Blockade of neurotensin receptors by the antagonist SR 48692 partially prevents retrograde axonal transport of neurotensin in rat nigrostriatal system by Steinberg, R, Bougault, I, Souilhac, J, Gully, D, Le Fur, G, Soubrié, P

    Published in Neuroscience letters (17-01-1994)
    “…The effect of SR 48692, a potent and selective non-peptide antagonist of the neurotensin receptor, was investigated on the retrograde axonal transport of…”
    Get more information
    Journal Article
  13. 13

    Neurochemical and behavioural effects of neurotensin vs [D-Tyr 11]neurotensin on mesolimbic dopaminergic function by Steinberg, R, Brun, P, Souilhac, J, Bougault, I, Leyris, R, Le Fur, G, Soubrié, DP

    Published in Neuropeptides (Edinburgh) (1995)
    “…Microinjection of neurotensin(1–13) or neurotensin(8–13) into the ventral tegmental area (VTA) of anaesthetized rats produced dose-dependent (1–100 pg)…”
    Get full text
    Journal Article
  14. 14

    Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D 2 function by Alonso, R, Voutsinos, B, Fournier, M, Labie, C, Steinberg, R, Souilhac, J, Le Fur, G, Soubrié, P

    Published in Neuroscience (1999)
    “…The present study investigated, in rats, whether blockade of cannabinoid CB 1 receptors may alter Fos protein expression in a manner comparable to that…”
    Get full text
    Journal Article
  15. 15

    Facilitation of striatal acetylcholine release by dopamine D 1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation by Steinberg, R, Souilhac, J, Rodier, D, Alonso, R, Emonds-Alt, X, Le Fur, G, Soubrié, P

    Published in Neuroscience (01-05-1998)
    “…The regulation of striatal cholinergic function by dopamine D 1 receptor activation was examined in vivo in urethane-anaesthetized rats with microdialysis…”
    Get full text
    Journal Article
  16. 16

    Control by tachykinin NK(2) receptors of CRF(1) receptor-mediated activation of hippocampal acetylcholine release in the rat and guinea-pig by Desvignes, C, Rouquier, L, Souilhac, J, Mons, G, Rodier, D, Soubrié, P, Steinberg, R

    Published in Neuropeptides (Edinburgh) (01-04-2003)
    “…In vivo microdialysis was employed to explore the effects of different selective non-peptides NK(1),NK(2) and NK(3) receptor antagonists on the corticotropin…”
    Get full text
    Journal Article
  17. 17

    Control by tachykinin NK 2 receptors of CRF 1 receptor-mediated activation of hippocampal acetylcholine release in the rat and guinea-pig by Desvignes, C., Rouquier, L., Souilhac, J., Mons, G., Rodier, D., Soubrié, P., Steinberg, R.

    Published in Neuropeptides (Edinburgh) (2003)
    “…In vivo microdialysis was employed to explore the effects of different selective non-peptides NK 1,NK 2 and NK 3 receptor antagonists on the corticotropin…”
    Get full text
    Journal Article
  18. 18

    Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug by Bizière, K, Kan, J P, Souilhac, J, Muyard, J P, Roncucci, R

    Published in Arzneimittel-Forschung (1982)
    “…Minaprine (3-[2-morpholino-ethlamino]-4-methyl-6-phenyl-pyridazine dihydrochloride; 30038CM; trade name in France: Cantor) is a new psychotropic drug. The…”
    Get more information
    Journal Article
  19. 19

    Blockade of cannabinoid receptors by SR141716 selectively increases fos expression in rat mesocorticolimbic areas via reduced dopamine D sub(2) function by Alonso, R, Voutsinos, B, Fournier, M, Labie, C, Steinberg, R, Souilhac, J, Fur, G L, Soubrie, P

    Published in Neuroscience (01-04-1999)
    “…The present study investigated, in rats, whether blockade of cannabinoid CB sub(1) receptors may alter Fos protein expression in a manner comparable to that…”
    Get full text
    Journal Article
  20. 20

    Facilitation of striatal acetylcholine release by dopamine D sub(1) receptor stimulation: Involvement of enhanced nitric oxide production via neurokinin-2 receptor activation by Steinberg, R, Souilhac, J, Rodier, D, Alonso, R, Emonds-Alt, X, Le Fur, G, Soubrie, P

    Published in Neuroscience (01-02-1998)
    “…The regulation of striatal cholinergic function by dopamine D sub(1) receptor activation was examined in vivo in urethane-anaesthetized rats with microdialysis…”
    Get full text
    Journal Article